Corrigendum: Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study

Bibliographic Details
Main Authors:	Shuqun Li, Junyi Wu, Jiayi Wu, Yangkai Fu, Zhenxin Zeng, Yinan Li, Han Li, Weijia Liao, Maolin Yan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Immunology
Subjects:	unresectable hepatocellular carcinoma TACE levantinib anti-PD-1 antibody immunotherapy nomogram
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1187423/full

Internet